Caring for patients using mitragynine-derived substances
Familiarize yourself with the differences in mitragynine-derived compounds. Understand how to identify and manage kratom use disorder and withdrawal from mitragynine-derived compounds. We’re joined by Dr. Jonathan Tanawan (Profile).
**Claim CME for this episode at** http://curbsiders.vcuhealth.org**curbsiders.vcuhealth.org!**
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.
Episodes | Subscribe | Spotify | iTunes | [CurbsidersAddictionMed@gmail.com](mailto:CurbsidersAddictionMed@gmail.com) | CME!
**Credits**
- Written and Produced, with Show Notes, Infographic, and Cover Art by Zina Huxley-Reicher, MD
- Hosts: Carolyn Chan, MD. MHS and Zina Huxley-Reicher, MD
- Reviewer: Kento Sonoda, MD, MPH
- Showrunner: Carolyn Chan, MD, MHS
- Technical Production: PodPaste
- Guest: Jonathan Tanawan, MD
**Show Segments**
- Intro, disclaimer, guest bio
- Guest one-liner, Picks of the Week*
- Case from Kashlak; Definitions
- Pharmacology of kratom and other mitragynine-based compounds
- How to take a mitragynine-specific substance use history
- Defining a use disorder
- Withdrawal from kratom
- Managing a use disorder with MOUD
- Legal landscape and regulation
- Outro
